Careers | Find us | Contact us
2024-12-18T16:09:19+00:0024 October 2024|
Dr Leopold Parts, Group Leader at the Wellcome Sanger Institute, studies the effects of DNA mutations by engineering variation in cells. After almost 10 years at Sanger, he has worked across different research areas and experienced significant changes in the field of biology. We spoke with Leo to hear his vision for the role of AI in enhancing gene editing and how it may revolutionise generative and synthetic genomics.
2024-05-21T16:19:58+01:0017 July 2023|
Prime editing is the latest technique that enables scientists to alter the DNA of a living cell. It builds on CRISPR-Cas9 technology, and offers the potential to edit human cells to treat genetic diseases.
2022-12-13T11:15:15+00:0016 August 2019|
Meet the next generation of genomic scientists who are benefiting from our founder's generosity
2022-12-17T21:33:43+00:0010 April 2019|
How Sanger scientists are using genetic surgery to understand the blueprint of life
2022-11-24T10:26:05+00:0020 December 2018|
Hayley Clissold from the Sanger Institute's policy team team explores the issues surrounding gene editing and human embryos
2022-11-24T10:10:28+00:006 December 2018|
Our Policy Lead, Sarion Bowers, explores the extraordinary claims that the world’s first genome edited babies have been born.
2018-11-29T15:35:59+00:0029 November 2018|
Anna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu's unverified announcement of gene editing the first human embryos that have been born
Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244
Wellcome Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA. UK
+44 (0)1223 834244
